01 September 2011: Clinical Research
The concentration of thiobarbituric acid reactive substances (TBARS) and paraoxonase activity in blood of patients with osteoarthrosis after endoprosthesis implantation
Dorota M. Olszewska-Słonina ABCDE , Dariusz Mątewski BDEF , Rafał Czajkowski CEF , Krzysztof J. Olszewski BDEF , Alina Woźniak G , Grażyna Odrowąż-Sypniewska DF , Kinga Lis DF , Dariusz Musiałkiewicz EF , Bogna Kowaliszyn C
DOI: 10.12659/MSM.881936
Med Sci Monit 2011; 17(9): CR498-504
Background
Bone tissue is dynamic and subject to a continuous formation and resorption process [1]. During this process there is a balance in the activities of osteoblasts and osteoclasts. Many reports have shown that reactive oxygen species (ROS) may be involved in the pathogenesis of bone loss and can contribute to degradation of the cartilage matrix.
The presence of oxygen free radicals (OFR) inside and outside cells causes many pathological processes including inflammation, carcinogenesis, age-related diseases, atherosclerosis, ischemia, and neurological diseases (Parkinson’s, Alzheimer’s) [2–5]. They may easily react with deoxyribonucleic acid, lipids and proteins because of very high reactivity. Their mode of action changes the biological functions of basal cell components and thus probably leads to inappropriate enzymic activation or inactivation, irreversible transformation, mutations and even cell death [6–8]. OFR causes the damage of protein physico-chemical structure, lipid peroxidation, nucleic acids injury and hyaluronic acid depolymerization [9].
Lipid peroxidation involves the process of oxidative decomposition of polyunsaturated fatty acids (PUFA) of membrane phospholipids, leading to formation of mixtures of lipid hydroperoxide, and aldehydic end-products such as MDA [10–12]. Lipid peroxidation changes permeability and fluidity of cell membranes. Bonner et al. [13] demonstrated that lipids, especially polyunsaturated fatty acids, accumulate with normal aging of cartilage. In several models of degenerative arthritis, lipid accumulation generally precedes local tissue degeneration [14,15]. Age-related changes in the lipid composition of cartilage could push the normally contained lipid peroxidation process into a state of uncontrolled oxidative stress, leading to the oxidation of cartilage collagen. Oxidation of collagen could cause fragmentation which makes collagen fibrils more brittle and prone to mechanical fatigue failure [16]. Such failure could initiate osteoarthritis.
One of the best-known products of OFR reaction with lipids is malondialdehyde (MDA), formed in the lipid peroxidation process [6,17].
MDA is believed to be largely responsible for cytopathological effects observed during oxidative stress of lipid peroxidation [10,11]. MDA reacts with histidine and lysine residues of proteins to form stable adducts. MDA in some conditions may also induce changes in DNA by cross-linking formation [18,19].
Serum paraoxonase (PON1) is a calcium-dependent esterase known to catalyze hydrolysis of organophosphates, aryl esters, lactones and hydroperoxides and is widely distributed among tissues such as the liver, kidneys, intestine and plasma [20–22]. PON1 is exclusively bound to high-density lipoprotein (HDL) and is recognized as an antioxidant enzyme because it hydrolyses lipid peroxides in oxidized lipoproteins [23,24]. PON1 activity was suggested to be inversely associated with oxidative stress in serum and macrophages [25]. In several groups of patients with diabetes, hypercholesterolemia, and cardiovascular disease who are under increased oxidative stress, the reduced activity of PON1 has been reported [26–28].
MDA has not been searched for together with the antioxidant enzyme PON1 in OA patients thus far. We aimed to determine a possible correlation between serum PON1 activities as known antioxidant and MDA levels, end-products of lipid peroxidation, induced by ROS for evaluating oxidative stress in OA patients.
Material and Methods
SUBJECTS:
Subjects included 36 women aged 46–78 (average age: 66.47±9.94) and 19 men aged 40–77 (average age: 59.05±10.75) with clinically recognised degenerative disease of hip or knee joint who had been treated in the Department of Orthopedics and Traumatology at the Ludwik Rydygier Collegium Medicum in Bydgoszcz (part of Nicolaus Copernicus University in Toruń). Unilateral or bilateral hip osteoarthritis had been reported in 46 patients (29 women and 17 men); OA of unilateral or bilateral knee joint disease in 9 patients (7 women and 2 men). In some of the patients other concomitant diseases had been reported, among which the most frequent were myocardial ischaemia, diabetes and hypothyreosis.
There were 26 women aged 24–90 (average age 64.03±14.57) and 28 men aged 32–89 (average age 61.86±14.68) with normal motor fitness in the control group.
The biochemical tests were conducted in the Department of Medical Biology at Ludwik Rydygier Collegium Medicum in Bydgoszcz. The research was approved by the Bioethics Committee at L. Rydygier Medical University in Bydgoszcz (KB/470/2004).
The material for the study was venous blood plasma, serum and erythrocytes. Blood was taken after fasting, from the cubital vein, during a routine exam and kept in dry and sterile test-tubes (Grainer Bio-one, Austria). In the group of patients blood was taken twice – once before the arthroplasty and once on the tenth day after the surgery.
The whole blood with addition of 3.2% sodium citrate was centrifuged at 4°C to obtain erythrocytes and plasma. The plasma was collected for assessing MDA level. After removing plasma, the cells were washed using 3 volumes of phosphate buffered saline (PBS). The haemoglobin concentration in the hemolysates was assayed with the colorimetric standard method using Drabkin’s reagent and expressed as g/dl.
The blood samples without anticoagulant, after complete clotting, were centrifuged for 10 min. at 3000 rotations per min., at 4°C. Serum from the samples was placed into Eppendorf test-tubes and kept frozen at −20°C until the marking of lysosomal enzymes was performed. Serum was thawed about an hour before the study.
CHEMICALS:
Thiobarbituric acid (TBA), trichloroacetic acid (TCA), adrenaline and hydrogen peroxide were purchased from Fluka (Sigma-Alrich Sp. z o.o, Poland), butylated hyroxytoluene (BHT) and paraoxon was from Aldrich (Sigma-Aldrich sp. z o.o, Poland). Folin phenol reagent, sodium carbonate, sodium potassium tartrate ×4 H20, copper sulfate, Folin-Ciocalteau solution, fibrinogen, and calcium chloride were purchased from POCH (Gliwice, Poland). Other reagents were of analytical grade.
DETERMINATION OF MDA LEVEL IN ERYTHROCYTES: The erythrocyte malondialdehyde (MDAe) level was determined according to the method of Buege and Aust [29] in Esterbauer and Cheeseman’s later modification [30]. This method is based on the reaction with thiobarbituric acid (TBA) in an acidic pH at 90–100°C. In the TBA test reaction, MDA or MDA-like substances (produced during lipid peroxidation) and TBA react with production of a pink pigment with a 532 nm absorption maximum. The specimens were joined with butylated hydroxytoluene (BHT) and TCA, then incubated at room temperature for 10 min and centrifuged (4000 g, 10 min.). The supernatants reacted with a mixture of TBA and TCA in a boiling water bath for 20 min. After cooling, the absorbance was read at 532 nm.
DETERMINATION MDA LEVEL IN BLOOD PLASMA:
The samples were mixed with mixture of TBA and trichloroacetic acid (TCA) in HCl to precipitate protein. The reaction was performed at pH 2–3 at 90°C for 20 min. The precipitate was pelleted by centrifugation at 4000 g at room temperature for 15 min. Absorption of supernatants was read at a wavelength of 532 nm.
The majority of TBARS are malondialdehydes, thus the concentration of MDA in blood plasma was expressed as nmol MDA/ml. The results were calculated using an index of absorption for MDA of 1.56×105/M/cm. The concentration of MDA in erythrocytes was expressed as nmol MDA/g Hb.
DETERMINATION OF PARAOXONASE ACTIVITY:
Paraoxonase activities were measured according to the method of Playfer et al. [31] with later modification of Sogorb et al. [32]. The assay buffer contained 0.1M TRIS-HCl (pH 9.0), 5 mM CaCl2. The reaction was initiated by adding blood serum to the freshly prepared paraoxon (diethyl-p-nitrophenyl phosphate), and the increase in absorbance was monitored at 412nm with the use of a continuously recording spectrophotometer. The rate of generation of p-nitrophenol was determined at 37°C. Enzyme activity was calculated from the rate of p-nitrophenol production (molar extinction coefficient – 18029 M/cm) and was expressed as units per l of blood serum (1U PON activity was defined as 1 μM paraoxon hydrolyzed min-1 under the above assay conditions).
STATISTICAL ANALYSIS:
The Statistical Package for Social Sciences (SPSS Inc., Chicago, USA, version 12.0) was used for the analyses. Kolmogorov-Smirnov and Shapiro-Wilks tests were applied for the compatibility estimation of the studied parameters’ distribution with normal distribution. All results are expressed as mean ±SD; differences between groups were assessed using non-parametric Mann-Whitney U-test. Spearman rank correlation (for categorical variables) and Pearson correlation coefficients were used to assess the relationship between parameters. A two-tailed P value of <0.05 was considered statistically significant.
Results
Characteristics of the study group are presented in Table 1. The results obtained in the studied group are presented together (Figure 1, Table 2) and separately with division into men and women (Table 3), and also into groups of patients under 69 and over 70 year of life (Table 4).
Concentration of malondialdehyde in all studied patients’ erythrocytes was higher than in the reference group; however, the stated difference was not statistically significant. Increased concentration of MDAe before surgery was noticed in the group of men with OA (64.42 nmol/g Hb, p<0.01). After implantation of the endoprosthesis, MDAe concentration in plasma decreased to the level found in the control groups. Only in the group of patients older than 70 did the postoperative concentration of MDAe differ significantly from the value of the parameter in the control group: accordingly (43.93
Regardless of the sex or age, paraoxonase activity was twice as high in all studied groups as in the reference group, and the differences were statistically significant.
PON1 activity after surgical treatment increased in serum of studied women (by 7%, p<0.05) and also the group of patients older than 70 (about 8%, p<0.05). In the other groups, endoprosthesis implantation resulted in a decrease of PON1 activity: male patients (19%, p<0.01) and younger patients (10%, p<0.01). A positive correlation between PON1 activity and MDAe concentration was demonstrated, both before and after surgery in the group of male patients (r=0.318; p<0.01).
Discussion
The assumption that extremely labile reactive oxygen species (ROS) may play a role in the regulation of tissue oxidation-antioxidant processes in articular cartilage seems to be problematic due to a lack of vascularization and oxygenation.
The decrease of PON1 activity after endoprosthesis implantation in examined men and younger persons confirms the results of experiments by Regan et al. [40], which proved a correlation between OA and the activity of ROS main scavengers in the articular cartilage, suggesting that damages caused by ROS play a key role at both initial and progressive stages of disease. Regan et al. also reported that with increasing body weight, excessive shear forces rooted in instability or improper setting of a joint in relation to its axis, as well as an excessive load of joint while performing daily activities, explain the increased activity of reactive particles in the articular cartilage. The ability of scavenging ROS within a joint may depend on genetic factors – it is possible that remaining under the influence of hormones, age at which first OA symptoms were observed, and other interindividual differences play a role. Buffering capacities of ROS can also be weakened by other diseases, in the course of which ROS are generated [40].
The other described joint element playing a vital role in the pathogenesis of OA is a synovial compartment [41]. Ayral et al. found that in the course of acute synovial inflammation, changes are observed in the nature of its proliferation and inflammation. Activated synovium may release proteases and cytokines that accelerate the deterioration of pathological changes adjacent to the synovial cartilage. Among some of our patients (especially those with post-traumatic and rheumatoid OA) high activity of PON1 before surgery may indicate acute inflammation of synovial joint. In the advanced stages of OA, “synovitis” may even resemble the image of synovial membrane inflammatory hyperplasia (pannus) observed in rheumatoid arthritis (RA) [42]. MDA, very harmful for an organism, being the final product of rapid oxidation of unsaturated fatty acids, is currently the most commonly assessed marker of lipid peroxidation. In numerous scientific studies, statistically higher levels of MDA were found in blood, synovial fluid and urine of patients with rheumatoid arthritis compared to the control group [43,44]. Our study also shows higher MDA concentration in erythrocytes of patients (aetiology of OA in 7 cases was rheumatoid) compared to the control group.
Tiku et al. [16] conducting
Consumption of PON1 to prevent oxidation results in a decrease of serum PON1 activity [51,52]. The protection against lipid peroxidation is achieved by PON1, during which free sulfhydryl groups of PON1 interact with specific oxidized lipids, and thus PON1 is inactivated [51]. Baskol et al. [43] concluded that the increased ROS levels might cause increased lipid peroxidation, and thus result in decreased antioxidant PON1 activity and increased serum MDA levels, and also determined a significant negative correlation between serum MDA and PON1 activities in the patient group. In our study the surgery seems (decreased PON1 activity and increased serum MDA but no significant correlation MDA/PON1) to cause an increase of ROS production in males and older patients.
Red blood cells are frequently used as an
Conclusions
Our research and statistical analysis of the obtained results show both an increased ROS generation and intensified lipid peroxidation in the course of OA. It is the peroxidation of lipids, more severe in the elderly, which probably plays a key role in the pathogenesis of osteoarthritis.
References
1. Eriksen EF, Cellular mechanisms of bone remodeling: Rev Endocr Metab Disord, 2010; 11(4); 219-27, pmid: 21188536
2. Birkner E, Zalejska-Fiolka J, Antoszewski Z, Antioxidant enzymes activity and role of antioxidant vitamins in Alzheimer disease: Post Hig Med Dosw, 2004; 58; 264-69
3. Cobbs CS, Samanta M, Harkins LE, Evidence for peroxynitrate-mediated modifications to p53 in human gliomas: possible functional consequences: Arch Biochem Biophys, 2001; 394; 167-72, pmid: 11594730
4. Pazdernik TL, The osmotic/calcium stress theory of brain damage is free radicals involved: Neurochem Res, 1992; 17; 11-21, pmid: 1538823
5. Valko M, Leibfritz D, Moncol J, Free radicals and antioxidants in normal physiological functions and human disease: Int J Biochem Cell Biol, 2007; 39(1); 44-84, pmid: 16978905
6. Halliwell B, Gutteridge JM: Free radicals in biology and medicine, 1993; 86-187, Oxford, Clarendon Press
7. Hinshaw DB, A cellular model of antioxidant mediated neuronal injury: Brain Res, 1993; 615; 13-26, pmid: 8364721
8. Tews DS, Cell death and oxidative stress in gliomas: Neuropathol Appl Neurobiol, 1999; 25; 272-84, pmid: 10476044
9. Prabha PS, Das UN, Koratkar R, Free radical generation, lipid peroxidation and essential fatty acids in uncontrolled essential hypertension: Prostaglandis Leukot Essent Fatty Acids, 1990; 41; 27-33
10. Esterbauer H, Schaur RJ, Zollner H, Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes: Free Radic Biol Med, 1991; 11(1); 81-128, pmid: 1937131
11. Poli G, Parola M, Oxidative damage and fibrogenesis: Free Radic Biol Med, 1997; 22(1–2); 287-305, pmid: 8958154
12. Girotti AW, Lipid hydroperoxide generation, turnover, and effector action in biological systems: J Lipid Res, 1998; 39(8); 1529-42, pmid: 9717713
13. Bonner WM, Jonsson H, Malanos C, Bryant M, Changes in the lipids of human articular cartilage with age: Arthritis Rheum, 1975; 18(5); 461-73, pmid: 1191347
14. Silberberg M, Silberberg R, Effects of a high fat diet on the joints of aging mice: AMA Arch Pathol, 1950; 50(6); 828-46, pmid: 14789326
15. Silberberg M, Silberberg R, Orcutt B, Modifying effect of linoleic acid on articular aging and osteoarthrosis in lard-fed mice: Gerontologia, 1965; 11(3); 179-87, pmid: 5865221
16. Tiku ML, Shah R, Allison GT, Evidence linking chondrocyte lipid peroxidation to cartilage matrix protein degradation. Possible role in cartilage aging and the pathogenesis of osteoarthritis: J Biol Chem, 2000; 275(26); 20069-76, pmid: 10867027
17. Smith CV: Free Radic Biol Med, 1991; 10; 217-24, pmid: 1864526
18. Dooley PA, Tsarouhtsis D, Korbel GA, Structural studies of an oligodeoxynucleotide containing a trimethylene interstrand cross-link in a 5′-(CpG) motif: model of a malondialdehyde cross-link: J Am Chem Soc, 2001; 123(8); 1730-39, pmid: 11456774
19. Oliński R, Jurgowiak M, Oxidative DNA base modifications and their role in ageing and degenerative disease: Post Biol Kom, 1999(Supl 3); 3-22
20. Draganov DI, La Du BN: Naunyn Schmiedebergs Arch Pharmacol, 2004; 369(1); 78-88, pmid: 14579013
21. La Du BN, Structural and functional diversity of paraoxonases: Nat Med, 1996; 2(11); 1186-87, pmid: 8898738
22. La Du BN, Adkins S, Kuo CL, Lipsig D, Studies on human serum paraoxonase/arylesterase: Chem Biol Interact, 1993; 87(1–3); 25-34, pmid: 8393742
23. Aviram M, Rosenblat M, Bisgaier CL, Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase: J Clin Invest, 1998; 101(8); 1581-90, pmid: 9541487
24. Mackness MI, Mackness B, Durrington PN, Paraoxonase: biochemistry, genetics and relationship to plasma lipoproteins: Curr Opin Lipidol, 1996; 7(2); 69-76, pmid: 8743898
25. Rozenberg O, Rosenblat M, Coleman R, Paraoxonase (PON1) deficiency is associated with increased macrophage oxidative stress: studies in PON1-knockout mice: Free Radic Biol Med, 2003; 34(6); 774-84, pmid: 12633754
26. Ayub A, Mackness MI, Arrol S, Serum paraoxonase after myocardial infarction: Arterioscler Thromb Vasc Biol, 1999; 19(2); 330-35, pmid: 9974415
27. Feretti G, Bacchetti T, Masciangelo S, Bicchiega V, HDL-paraoxonase and membrane lipid peroxidation: a comparison between healthy and obese subjects: Obesity (Silver Spring), 2010; 18(6); 1079-84, pmid: 19834469
28. Mackness MI, Harty D, Bhatnagar D, Serum paraoxonase activity in familial hypercholesterolaemia and insulin-dependent diabetes mellitus: Atherosclerosis, 1991; 86(2–3); 193-99, pmid: 1651732
29. Buege SC, Aust SD, Microsomal lipid peroxidation: Methods Enzymol, 1987; 51; 302-10
30. Esterbauer H, Cheeseman KH, Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal: Method Enzymol, 1990; 186; 407-21
31. Playfer JR, Eze LC, Bullen MF, Evans DA, Genetic polymorphism and interethnic variability of plasma paraoxonase activity: J Med Genet, 1976; 13; 337-42, pmid: 1003443
32. Sogorb MA, Díaz-Alejo N, Escudero MA, Vilanova E, Phosphotriesterase activity identified in purified serum albumins: Arch Toxicol, 1998; 72(4); 219-26, pmid: 9587017
33. Silver IA, Measurement of pH and ionic composition of pericellular sites: Philos Trans R Soc Lond B Biol Sci, 1975; 271(912); 261-72, pmid: 239420
34. Monboisse JC, Borel JP, Oxidative damage to collagen: EXS, 1992; 62; 323-27, pmid: 1333311
35. McCord JM, Free radicals and inflammation: protection of synovial fluid by superoxide dismutase: Science, 1974; 185(150); 529-31, pmid: 4841157
36. Kempson GE, Muir H, Pollard C, Tuke M, The tensile properties of the cartilage of human femoral condyles related to the content of collagen and glycosaminoglycans: Biochim Biophys Acta, 1973; 297(2); 456-72, pmid: 4267503
37. Zielaskowska J, Olszewska-Słonina D, The polymorphism of paraoxonase and its effects in physiological and pathological processes: Adv Clin Exp Med, 2006; 15(6); 1073-78
38. Ozkök E, Aydin M, Babalik E, Combined impact of matrix metalloproteinase-3 and paraoxonase 1 55/192 gene variants on coronary artery disease in Turkish patients: Med Sci Monit, 2008; 14(10); CR536-42, pmid: 18830194
39. Camps J, Marsillach J, Joven J, The paraoxonases: role in human diseases and methodological difficulties in measurement: Crit Rev Clin Lab Sci, 2009; 46(2); 83-106, pmid: 19255916
40. Regan E, Flannelly J, Bowler R, Extracellular superoxide dismutase and oxidant damage in osteoarthritis: Arthritis Rheum, 2005; 52(11); 3479-91, pmid: 16255039
41. Ayral X, Pickering EH, Woodworth TG, Synovitis: a potential predictive factor of structural progression of medial tibiofemoral knee osteoarthritis – results of a 1 year longitudinal arthroscopic study in 422 patients: Osteoarthritis Cartilage, 2005; 13(5); 361-67, pmid: 15882559
42. Shibakawa A, Aoki H, Masuko-Hongo K, Presence of pannus-like tissue on osteoarthritic cartilage and its histological character: Osteoarthritis Cartilage, 2003; 11(2); 133-40, pmid: 12554129
43. Baskol G, Demir H, Baskol M, Assessment of paraoxonase 1 activity and malondialdehyde levels in patients with rheumatoid arthritis: Clin Biochem, 2005; 38; 951-55, pmid: 16055108
44. Jaswal S, Mehta HC, Sood AK, Kaur J, Antioxidant status in rheumatoid arthritis and role of antioxidant therapy: Clin Chim Acta, 2003; 338; 123-29, pmid: 14637276
45. van Acker SA, Koymans LM, Bast A, Molecular pharmacology of vitamin E: structural aspects of antioxidant activity: Free Radic Biol Med, 1993; 15(3); 311-28, pmid: 8406131
46. Gutteridge JM, Lipid peroxidation and antioxidants as biomarkers of tissue damage: Clin Chem, 1995; 41(12 Pt 2); 1819-28, pmid: 7497639
47. Tanimoto N, Kumon Y, Suehiro T, Serum paraoxonase activity decreases in rheumatoid arthritis: Life Sci, 2003; 72(25); 2877-85, pmid: 12697270
48. Verzijl N, Bank RA, TeKoppele JM, DeGroot J, Ageing and osteoarthritis: a different perspective: Curr Opin Rheumatol, 2003; 15(5); 616-22, pmid: 12960490
49. Carrington JL, Aging bone and cartilage: cross-cutting issues: Biochem Biophys Res Commun, 2005; 328(3); 700-8, pmid: 15694404
50. Murphy JM, Dixon K, Beck S, Reduced chondrogenic and adipogenic activity of mesenchymal stem cells from patients with advanced osteoarthritis: Arthritis Rheum, 2002; 46(3); 704-13, pmid: 11920406
51. Göçmen YA, Gümüşlü S, Semiz E, Association between paraoxonase-1 activity and lipid peroxidation indicator levels in people living in the Antalya region with angiographically documented coronary artery disease: Clin Cardiol, 2004; 27(7); 426-30, pmid: 15298047
52. Göçmen YA, Semiz E, Gümüşlü S, Relationship between paraoxonase-1 (PON1) activity and lipoprotein (a) levels in Turkish coronary artery disease patients living in the Antalya region: Eur J Cardiovasc Prev Rehabil, 2005; 12(2); 185-86, pmid: 15785307
53. Sawicka E, Długosz A, Roszkowska A, Synergistic effect of Scutellaria baicalensis extract and Q10 coenzyme: Bromat Chem Toksykol, 2009; XLII(1); 59-64
In Press
Clinical Research
Institutional and Regional Variations in Access to Clinical Trials and Next-Generation Sequencing in Turkis...Med Sci Monit In Press; DOI: 10.12659/MSM.951027
Clinical Research
Low-Intensity Blood Flow-Restricted Multi-Joint Exercise Improves Muscle Function in Patients With Patellof...Med Sci Monit In Press; DOI: 10.12659/MSM.950516
Review article
Musculoskeletal Ultrasound and MRI in the Evaluation of Chemotherapy-Induced Peripheral Neuropathy: A ReviewMed Sci Monit In Press; DOI: 10.12659/MSM.951283
Clinical Research
Sensory Processing, Dissociation, and Affective Symptoms in Misophonia: A Cross-Sectional Study of 35 AdultsMed Sci Monit In Press; DOI: 10.12659/MSM.950938
Most Viewed Current Articles
17 Jan 2024 : Review article 10,187,196
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
13 Nov 2021 : Clinical Research 3,708,487
Acceptance of COVID-19 Vaccination and Its Associated Factors Among Cancer Patients Attending the Oncology ...DOI :10.12659/MSM.932788
Med Sci Monit 2021; 27:e932788
14 Dec 2022 : Clinical Research 2,341,643
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
16 May 2023 : Clinical Research 706,524
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387






